Abstract: The present technology is directed to composition that may be formulated for parenteral administration, where the composition includes a plurality of nanoparticles and optionally a pharmaceutically acceptable carrier. Each nanoparticle of the plurality includes a glatiramoid and one or more of a polyinosine-polycytidylic acid (Poly(I:C)), a plasmid DNA (pDNA), a CpG oligodeoxynucleotide (CpG ODN), or a combination of any two or more thereof.

Abstract: A prostate grasping morcellator device and a method of morcellating prostate tissue are described. The prostate grasping morcellator device includes a handpiece portion including a motor which rotates an internal sheath in an external sheath of a rod. The rod is connected to a second end of the handpiece portion. The prostate grasping morcellator device includes one or more retractable grasping nails connected to an end of the rod. The end is distal to the second end of the handpiece portion. The prostate grasping morcellator device includes a control button to control movement of the retractable grasping nails. The control button is mounted adjacent to the second end of the handpiece portion. The prostate grasping morcellator device includes one or more blades, rotated by the motor to morcellate tissue.

Abstract: The present technology is directed to composition that may be formulated for parenteral administration, where the position includes a plurality of nanoparticles and optionally a pharmaceutically acceptable carrier. Each nanoparticle of the plurality includes a glatiramoid and one or more of a polyinosine-polycytidylic acid (Poly(LC)), a plasmid DNA (pDNA), a CpG oligodeoxynucleotide (CpG ODN), or a combination of any two or more thereof.